Navigation Links
InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
Date:2/7/2008

the safety and

tolerability results of ITMN-191 were excellent.

-- That the trial had achieved its principal goals for viral kinetic

performance, safety and tolerability to advance the program into a

triple combination study with Pegasys(R) and ribavirin.

-- It expected to complete enrollment of the third dose cohort in the

MAD study in January 2008. InterMune announced today that

enrollment of that cohort was completed in late January and that

data from the third cohort are not yet available to the company.

-- InterMune expects to begin a 14-day triple combination study of

ITMN-191 with Pegasys(R) and ribavirin in the second quarter of

2008.

Guidance for 2008 Operating Expenses

InterMune today provided its forward-looking guidance with respect to operating expenses in 2008.

For the year ending December 31, 2008, R&D expense is anticipated to be similar to 2007 in a range of approximately $100 to $110 million, net of development cost reimbursements under the Roche collaboration. G&A expense is anticipated to be in a range of approximately $25 to $30 million.

Key Development Program Milestones

InterMune today noted the upcoming milestones with respect to its key development programs.

CAPACITY Program in IPF:

-- InterMune expects to announce top-line results of its Phase 3 CAPACITY

program in IPF in January of 2009.

ITMN-191 Program in HCV:

-- In conjunction with its partner, Roche, InterMune has decided to

complete a fourth cohort of the Phase 1b multiple-ascending-dose (MAD)

study to further inform the planned 14-day triple therapy study and

potential direct anti-viral combination studies in the future.

Consequently, InterMune has decided to announce results from the first

four cohorts of the Phase lb MAD study
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015  Twelve patients today are preparing to participate ... at California Pacific Medical Center (CPMC), a Sutter Health ... will be the largest single-center kidney paired donation chain ... in the 44-year history of the CPMC Transplant Center. ... an altruistic donor who did not have a specific ...
(Date:3/5/2015)... Buffalo, New York (PRWEB) March 05, 2015 ... want veterans to be able to get an Advanced ... Time, money, stress, blaming and guessing are all risk ... with assuming the woman is the source of the ... and female. LifeCell Dx has the simplest, least ...
(Date:3/5/2015)... BioPlus Specialty Pharmacy (BioPlus) announces the hiring ... of Managed Care. In this role, Damm will build ... nation’s leading specialty pharmacies. , Damm, who is based ... pharmacy and biotech experience to his new position with ... and Pfizer. Prior to working in Healthcare Damm served ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 North ... Pierre Noel, M.D., Professor of Medicine, Mayo Clinic ... Company’s Board of Directors. , Entegrion’s ... extremely fortunate to have Dr. Noel, a distinguished ... healthcare organization, join Entegrion’s Board. His expertise in ...
Breaking Biology Technology:Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 2Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 3Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 4LifeCell Dx Offers New Option to Veterans with Infertility 2LifeCell Dx Offers New Option to Veterans with Infertility 3BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm 2Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2
... MaxCyte, Inc., a,clinical-stage therapeutics company and pioneer ... that Anthony Recupero, Ph.D.,Vice President Business Development ... 2008, at 2:00PM at the BIO-Europe Spring ... will discuss the development of,engineered cell based ...
... continues to advance collaborative research worldwide, ... Biosystems, Inc.,announced today that leading research institutions, ... at the University of,Queensland, and the Biotech ... University of Copenhagen have recently purchased access ...
... 2008 /Xinhua-PRNewswire-FirstCall/ -- China YCT,International Group Inc. (OTC ... subsidiary, Shandong Spring Pharmaceutical Co., Ltd, has,entered into ... Tang,Bioengineering Co. Ltd., effective as of April 4, ... manage the operations of,Shandong Yong Chun Tang, in ...
Cached Biology Technology:Open Biosystems' Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland 2Open Biosystems' Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland 3China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier 2China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier 3
(Date:2/5/2015)... Calif. , Jan. 27, 2015 /PRNewswire/ ... provider of globally deployed, innovative test solutions ... announced the delivery of its TS-323 ... Space Systems Company (LMSSC). GENASYS is a ... demands of mission-critical applications that require performance ...
(Date:2/5/2015)... MOUNTAIN VIEW, Calif. , Feb. 3, 2015 ... screen printer technology, demand from industries such as ... the global market for surface mount technology (SMT) ... manual equipment to automatic control will push the ... glue dispensers will remain steady as glue dispensers ...
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , ... it will showcase its EyeLock ID technology integrated in a ... Energy,s Oak Ridge National Laboratory (ORNL) at the ... identity authentication technology is being used to validate the driver ...
Breaking Biology News(10 mins):Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... Scientists trying to understand why oaks are starting to ... just below the surface to find some answers. ... small rodents that live underground, prefer oak roots to ... the rodents as a possible factor leading to high ...
... 2009 As we move more toward renewable energy, questions ... If so, are humans or natural variations in climate ... research and atmospheric science will address such questions during a ... His talk is free and open to the public. ...
... Zoo post-doctoral researcher Carson Murray, Ph.D. has received a ... world,s foremost medical research centers, the National Institutes of ... Rachel Santymire, Ph.D. of Lincoln Park Zoo and Martha ... to identify stressors of wild female chimpanzees and discover ...
Cached Biology News:Danger lurks underground for oak seedlings 2Prominent climate researcher to speak at UH on global warming March 5 2Lincoln Park Zoo scientists awarded National Institutes of Health grant 2